671 related articles for article (PubMed ID: 28302125)
1. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
Seyoum A; Ndlovu P; Temesgen Z
AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125
[TBL] [Abstract][Full Text] [Related]
2. Determinants of CD4 cell count change and time-to default from HAART; a comparison of separate and joint models.
Tegegne AS; Ndlovu P; Zewotir T
BMC Infect Dis; 2018 Apr; 18(1):197. PubMed ID: 29703155
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study.
Tegegne AS; Ndlovu P; Zewotir T
BMC Infect Dis; 2018 Feb; 18(1):83. PubMed ID: 29458343
[TBL] [Abstract][Full Text] [Related]
4. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.
Gezie LD
BMC Res Notes; 2016 Jul; 9():377. PubMed ID: 27475982
[TBL] [Abstract][Full Text] [Related]
5. Quasi-Poisson versus negative binomial regression models in identifying factors affecting initial CD4 cell count change due to antiretroviral therapy administered to HIV-positive adults in North-West Ethiopia (Amhara region).
Seyoum A; Ndlovu P; Zewotir T
AIDS Res Ther; 2016; 13():36. PubMed ID: 27843481
[TBL] [Abstract][Full Text] [Related]
6. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
Diabaté S; Alary M
HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
[TBL] [Abstract][Full Text] [Related]
7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
8. Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia.
Ebissa G; Deyessa N; Biadgilign S
AIDS Care; 2015; 27(6):723-30. PubMed ID: 25599414
[TBL] [Abstract][Full Text] [Related]
9. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
10. Time to initial highly active antiretroviral therapy discontinuation and its predictors among HIV patients in Felege Hiwot comprehensive specialized hospital: a retrospective cohort study.
Amera TG; Bogale KA; Tefera YM
AIDS Res Ther; 2021 Dec; 18(1):93. PubMed ID: 34863200
[TBL] [Abstract][Full Text] [Related]
11. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with adherence to highly active antiretroviral therapy among children in two referral hospitals, northwest Ethiopia.
Azmeraw D; Wasie B
Ethiop Med J; 2012 Apr; 50(2):115-24. PubMed ID: 22924280
[TBL] [Abstract][Full Text] [Related]
14. Predictors for CD4 cell count and hemoglobin level with survival time to default for HIV positive adults under ART treatment at University of Gondar Comprehensive and Specialized Hospital, Ethiopia.
Muhie NS; Tegegne AS
BMC Res Notes; 2023 Dec; 16(1):357. PubMed ID: 38042846
[TBL] [Abstract][Full Text] [Related]
15. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
16. Predictors of change in CD4 lymphocyte count and weight among HIV infected patients on anti-retroviral treatment in Ethiopia: a retrospective longitudinal study.
Reda AA; Biadgilign S; Deribew A; Gebre B; Deribe K
PLoS One; 2013; 8(4):e58595. PubMed ID: 23573191
[TBL] [Abstract][Full Text] [Related]
17. Immunological Response of Hiv-Infected Children to Highly Active Antiretoviral Therapy at Gondar University Hospital, North-Western Ethiopia.
Kokeb M; Degu G
Ethiop J Health Sci; 2016 Jan; 26(1):25-30. PubMed ID: 26949313
[TBL] [Abstract][Full Text] [Related]
18. Joint Modeling in Detecting Predictors of CD4 Cell Count and Status of Tuberculosis Among People Living with HIV/AIDS Under HAART at Felege Hiwot Teaching and Specialized Hospital, North-West Ethiopia.
Bayabil S; Seyoum A
HIV AIDS (Auckl); 2021; 13():527-537. PubMed ID: 34040450
[TBL] [Abstract][Full Text] [Related]
19. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
